A single center clinical study of EGFR/HER2 targeted inhibitor Lapatinib in the treatment of refractory Cushing's disease A single center clinical study of EGFR/HER2 targeted inhibitor Lapatinibin the treatment of refracto ...
A single center clinical study of EGFR/HER2 targeted inhibitor Lapatinib in the treatment of refractory Cushing's disease A single center clinical study of EGFR/HER2 targeted inhibitor Lapatinibin the treatment of refracto ...